The global whole genome bisulfite sequencing market size was calculated at USD 367.07 million in 2024 and is predicted to attain around USD 1,496.49 million by 2034, expanding at a CAGR of 16.9% from 2025 to 2034.
| Industry Worth | Details |
| Market Size in 2025 | USD 367.07 Million |
| Market Size by 2034 | USD 1,496.49 Million |
| Market Growth Rate from 2025 to 2034 | CAGR of 16.9% |
The whole genome bisulfite sequencing market refers to the production, distribution, and application of whole genome bisulfite sequencing (WGBS) is a method that uses bisulfite treatment to convert unmethylated cytosines (C) in the genome, distinguishing methylated from unmethylated cytosines, coupled with high-throughput sequencing technology to determine methylation status at CpG/CHG/CHH sites. Whole genome bisulfite sequencing (WGBS) is a well-established protocol to detect methylated cytosines in genomic DNA. In this method, genomic DNA is treated with sodium bisulfite and then sequenced, providing a single base resolution of methylated cytosines in the genome. The benefits of whole genome bisulfite sequencing (WGBS) include maximally obtaining comprehensive whole genome methylation information, and accurately mapping methylation patterns.
Providing insights into gene cell fate commitment and reprogramming, as well as gene regulation. Identifying new epigenetics marks and disease targets. Bisulfite genomic sequencing is regarded as a gold standard technology for the detection of DNA methylation because it provides a qualitative, quantitative, and effective approach to identifying 5-methylcytosine at single base pair resolution.
Rising demand for whole genome sequencing for genome mapping programs driving the growth of the whole genome bisulfite sequencing market. Whole genome sequencing plays a significant role in understanding genome profile, gene alteration, and mutation. This information helps in developing personalized medicine to target disease at a genetic level. Mapping an individual’s DNA can help scientists study gene mutations that cause diseases, including cancer, and could allow doctors to prescribe personalized precision in the future.
Genetic mapping benefits also include the genetic map helps scientists understand the complexity and genetic organization of a species, genetic maps can help us understand the evolutionary relationships between species, and information on genetic maps can be used to diagnose inherited human diseases. A genome is the book of life is the entire set of genetic information about a person or organism. Genetic mapping is generally employed for locational analyses of shape variations between two parents with markedly different traits and offspring populations with many phenotypic traits. In genetics, mapping functions are used to model the relationship between map distances and recombination frequencies, mainly as these measurements relate to regions encompassed between genetic markers.
Advancements in sequencing technologies driving the growth of the whole genome bisulfite sequencing market. Recent advancements have focused on faster and more accurate sequencing, reduced costs, and enhanced data analysis. The advancements hold great promise for unlocking new insights into genomics and enhancing our understanding of diseases and personalized healthcare.
The benefits of next-generation sequencing (NGS) technology include faster and cost-effective studies, higher accuracy, and lower sample input requirements. It is a powerful technique for studying DNA and other genetic material. It allows researchers to quickly and accurately sequence large amounts of DNA, providing valuable insights into the genetic makeup of organisms. Key benefits of NGS include accessibility to whole genome sequencing, a broad dynamic range for expression profiling, and tunable resolution for targeted NGS.
Published by Ajit Bansod
